SCHEMBL6203985

SCHEMBL6203985

COc1cccc(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70822 1.00 — —
SCHEMBL29635640 1.00 — —
SCHEMBL1794813 0.98 ACHE (0.54) —
Water SCHEMBL27909580 0.98 ACHE (0.54) —
Naphthalene SCHEMBL10873174 0.91 CYP2A6 (0.59) —
SCHEMBL9628833 0.91 RELA (0.58) —
SCHEMBL4621505 0.91 NPC1 (0.51) —
SCHEMBL792094 0.87 CYP1A1 (0.57) —
Boric Acid SCHEMBL27272586 0.86 ENPP2 (0.52) —
Phenol SCHEMBL28303203 0.86 TSHR (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 — — EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 — — WO disclosed
Send feedback